J
Jon Alm Eriksen
Researcher at University of Oslo
Publications - 21
Citations - 692
Jon Alm Eriksen is an academic researcher from University of Oslo. The author has contributed to research in topics: Genome-wide association study & Pattern formation. The author has an hindex of 10, co-authored 19 publications receiving 589 citations. Previous affiliations of Jon Alm Eriksen include Ecole et Observatoire des Sciences de la Terre & Norsk Hydro.
Papers
More filters
Journal ArticleDOI
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
P. Brunsvig,Steinar Aamdal,Marianne Klemp Gjertsen,Gunnar Kvalheim,Carrie J. Markowski-Grimsrud,Ingunn Sve,Marianne Dyrhaug,Sissel Trachsel,Mona Møller,Jon Alm Eriksen,Gustav Gaudernack +10 more
TL;DR: The results demonstrate that GV1001 and HR2822 are immunogenic and safe to use in patients with NSCLC.
Journal ArticleDOI
Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function.
Olav B. Smeland,Olav B. Smeland,Olav B. Smeland,Oleksandr Frei,Karolina Kauppi,Karolina Kauppi,W. David Hill,Wen Li,Yunpeng Wang,Yunpeng Wang,Florian Krull,Francesco Bettella,Jon Alm Eriksen,Aree Witoelar,Gail Davies,Chun Chieh Fan,Wesley K. Thompson,Max Lam,Todd Lencz,Todd Lencz,Chi-Hua Chen,Torill Ueland,Erik G. Jönsson,Erik G. Jönsson,Erik G. Jönsson,Srdjan Djurovic,Srdjan Djurovic,Ian J. Deary,Anders M. Dale,Ole A. Andreassen,Ole A. Andreassen +30 more
TL;DR: The discovered loci improve the understanding of the common genetic basis underlying schizophrenia and cognitive function, suggesting novel molecular genetic mechanisms.
Journal ArticleDOI
A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells
TL;DR: A new cytotoxic T lymphocyte (CTL) epitope is defined, carrying a good HLA-A*0201 binding motif, and resulting from the most common frameshift mutation in TGFβRII, which may be a valuable component in cancer vaccines directed at MSI-positive carcinomas.
Journal ArticleDOI
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
Arvid Rongve,Aree Witoelar,Aree Witoelar,Agustín Ruiz,Lavinia Athanasiu,Lavinia Athanasiu,Carla Abdelnour,Jordi Clarimón,Stefanie Heilmann-Heimbach,Isabel Hernández,Sonia Moreno-Grau,Itziar de Rojas,Estrella Morenas-Rodríguez,Tormod Fladby,Tormod Fladby,Sigrid Botne Sando,Geir Bråthen,Frédéric Blanc,Olivier Bousiges,Afina W. Lemstra,Afina W. Lemstra,Inger van Steenoven,Inger van Steenoven,Elisabet Londos,Ina S. Almdahl,Ina S. Almdahl,Lene Pålhaugen,Lene Pålhaugen,Jon Alm Eriksen,Jon Alm Eriksen,Srdjan Djurovic,Srdjan Djurovic,Eystein Stordal,Eystein Stordal,Ingvild Saltvedt,Ingun Ulstein,Ingun Ulstein,Francesco Bettella,Rahul S. Desikan,Ane-Victoria Idland,Mathias Toft,Mathias Toft,Lasse Pihlstrøm,Jon Snaedal,Lluís Tárraga,Mercè Boada,Alberto Lleó,Hreinn Stefánsson,Kari Stefansson,Alfredo Ramirez,Alfredo Ramirez,Dag Aarsland,Dag Aarsland,Ole A. Andreassen,Ole A. Andreassen +54 more
TL;DR: Two susceptibility loci for DLB at genome-wide significance are reported, providing insight into etiological factors, and highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.
Journal ArticleDOI
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
Robert E. Hunger,Kristin Kernland Lang,Carrie J. Markowski,Sissel Trachsel,Mona Møller,Jon Alm Eriksen,Anne Marie Rasmussen,Lasse R. Braathen,Gustav Gaudernack +8 more
TL;DR: These results demonstrate that immunity to hTERT can be generated safely and effectively in patients with advanced melanoma and therefore encourage further trials.